ES2165878T3 - Utilizacion del modafinil para el tratamiento de las apneas del sueño y trastornos de ventilacion de origen central. - Google Patents

Utilizacion del modafinil para el tratamiento de las apneas del sueño y trastornos de ventilacion de origen central.

Info

Publication number
ES2165878T3
ES2165878T3 ES94919708T ES94919708T ES2165878T3 ES 2165878 T3 ES2165878 T3 ES 2165878T3 ES 94919708 T ES94919708 T ES 94919708T ES 94919708 T ES94919708 T ES 94919708T ES 2165878 T3 ES2165878 T3 ES 2165878T3
Authority
ES
Spain
Prior art keywords
modafinil
treatment
pct
central origin
sleep apneas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94919708T
Other languages
English (en)
Spanish (es)
Inventor
Philippe Laurent
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9448411&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2165878(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Application granted granted Critical
Publication of ES2165878T3 publication Critical patent/ES2165878T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Control Of Throttle Valves Provided In The Intake System Or In The Exhaust System (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES94919708T 1993-06-22 1994-06-14 Utilizacion del modafinil para el tratamiento de las apneas del sueño y trastornos de ventilacion de origen central. Expired - Lifetime ES2165878T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9307555A FR2706767B1 (OSRAM) 1993-06-22 1993-06-22

Publications (1)

Publication Number Publication Date
ES2165878T3 true ES2165878T3 (es) 2002-04-01

Family

ID=9448411

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94919708T Expired - Lifetime ES2165878T3 (es) 1993-06-22 1994-06-14 Utilizacion del modafinil para el tratamiento de las apneas del sueño y trastornos de ventilacion de origen central.

Country Status (14)

Country Link
US (1) US5612379A (OSRAM)
EP (1) EP0705099B1 (OSRAM)
JP (1) JP3703831B2 (OSRAM)
KR (1) KR100315389B1 (OSRAM)
AT (1) ATE207351T1 (OSRAM)
AU (1) AU684087B2 (OSRAM)
CA (1) CA2165824C (OSRAM)
DE (1) DE69428791T2 (OSRAM)
DK (1) DK0705099T3 (OSRAM)
ES (1) ES2165878T3 (OSRAM)
FR (1) FR2706767B1 (OSRAM)
HU (1) HU216731B (OSRAM)
PT (1) PT705099E (OSRAM)
WO (1) WO1995000132A1 (OSRAM)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
PT1066036E (pt) 1998-02-27 2006-09-29 Univ Illinois Agentes com actividade relacionada com serotonina para o tratamento da apneia do sono
US6492396B2 (en) 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
BR0114814A (pt) * 2000-10-11 2005-01-25 Cephalon Inc Composições compreendendo composto de modafinila e seu uso
MXPA03010705A (es) * 2001-05-25 2004-05-27 Cephalon Inc Formulaciones farmaceuticas solidas que comprenden modafinil.
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040116532A1 (en) 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
IL153098A0 (en) * 2002-11-26 2003-06-24 Chemagis Ltd Pharmaceutical compositions containing modafinil
US7528172B2 (en) * 2003-01-21 2009-05-05 The Cooper Health System, Inc. Compositions and methods for improving recovery after general anesthesia
CA2519117C (en) * 2003-03-17 2010-03-02 Neurohealing Pharmaceuticals, Inc. High potency dopaminergic treatment of neurological impairment associated with brain injury
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US7423176B2 (en) * 2004-04-13 2008-09-09 Cephalon, Inc. Bicyclic aromatic sulfinyl derivatives
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
EP1586560A1 (en) * 2004-04-13 2005-10-19 Cephalon, Inc. Thio-substituted arylmethanesulfinyl derivatives
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
US7297817B2 (en) * 2004-04-13 2007-11-20 Cephalon France Thio-substituted arylmethanesulfinyl derivatives
US7314875B2 (en) * 2004-04-13 2008-01-01 Cephalon, Inc. Tricyclic aromatic and bis-phenyl sulfinyl derivatives
CN101132777A (zh) * 2004-12-20 2008-02-27 科利吉姆制药公司 用于睡眠障碍的药物组合物
WO2007013962A2 (en) * 2005-07-21 2007-02-01 Neurohealing Pharmaceuticals, Inc. Rapid onset and short term modafinil compositions and methods of use thereof
MX2009000391A (es) * 2006-07-12 2009-06-30 Elan Pharma Int Ltd Formulación de modafinilo en forma de nano-partículas.
JP5395663B2 (ja) * 2006-08-14 2014-01-22 ニューロヒーリング・ファーマシューティカルズ・インコーポレーテッド モダフィニルによる早漏の治療
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
WO2008077127A2 (en) * 2006-12-19 2008-06-26 Lavin Thomas N Use of modafinil to treat restless leg syndrome
CN102781446A (zh) * 2010-01-07 2012-11-14 维瓦斯公司 采用碳酸酐酶抑制剂和另外的活性剂的组合治疗阻塞性睡眠呼吸暂停综合征
WO2015030283A1 (ko) 2013-08-30 2015-03-05 주식회사 녹십자에이치에스 진세노사이드 성분이 증가된 가공인삼분말 또는 가공인삼추출물을 함유하는 암 관련 피로의 예방 및 치료용 조성물
US9616068B2 (en) 2014-10-27 2017-04-11 Pohela LLC Animal training using cognitive enhancement

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1584462A (en) * 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
FR2684875B1 (fr) * 1991-12-13 1995-05-24 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.
US5281607B1 (en) * 1992-10-08 1998-05-19 Univ New York Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
KR960703009A (ko) 1996-06-19
FR2706767A1 (OSRAM) 1994-12-30
US5612379A (en) 1997-03-18
DE69428791D1 (de) 2001-11-29
JP3703831B2 (ja) 2005-10-05
EP0705099A1 (fr) 1996-04-10
CA2165824A1 (fr) 1995-01-05
DE69428791T2 (de) 2002-07-04
DK0705099T3 (da) 2002-02-11
AU7076094A (en) 1995-01-17
HUT74674A (en) 1997-01-28
WO1995000132A1 (fr) 1995-01-05
ATE207351T1 (de) 2001-11-15
PT705099E (pt) 2002-03-28
HU9503702D0 (en) 1996-02-28
AU684087B2 (en) 1997-12-04
HU216731B (hu) 1999-08-30
EP0705099B1 (fr) 2001-10-24
KR100315389B1 (ko) 2002-02-19
CA2165824C (fr) 2005-08-02
JPH09500374A (ja) 1997-01-14
FR2706767B1 (OSRAM) 1995-09-08

Similar Documents

Publication Publication Date Title
ES2165878T3 (es) Utilizacion del modafinil para el tratamiento de las apneas del sueño y trastornos de ventilacion de origen central.
GB0223038D0 (en) Therapeutic compounds
DE69400799D1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
DE60207383D1 (de) Ibuprofen und diphenhydramin enthaltende zusammensetzungen und deren verwendung zur behandlung von schlafstörungen
ATE262895T1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
BR9814280A (pt) Arilpiperazinas que apresentam atividade noreceptor 1a de serotonina
IL163026A (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
DK1463735T3 (da) Imidazo-2,1-B -1,3,4-thiadiazol-sulfonamider
NO20002218D0 (no) Anvendelse av mirtazepin for behandling av søvnapne
EE200100125A (et) TAN-1057 derivaadid
ES2193065T3 (es) Nueva utilizacion del saredutant.
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
ATE143946T1 (de) N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten
DE60228988D1 (de) Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen
ES2147796T3 (es) Composicion para el tratamiento o la prevencion del herpes.
ATE418973T1 (de) Spirocyclopropyl-amide und -säuren und ihre therapeutischen anwendungen
PT966455E (pt) Acidos oxiranocarboxilicos para o tratamento da diabetes
PT1282414E (pt) Compostos derivados de felbamato para o tratamento da dor neuropatica
ES2140544T3 (es) Utilizacion de efaroxan y de sus derivados para la fabricacion de medicamentos destinados al tratamiento de las enfermedades neurodegenerativas.
DE60326348D1 (de) Makrozyclen zur behandlung von krebserkrankungen
ATE385792T1 (de) Verwendung von derivaten von c2-substituierten indan-1-ol-systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas
PL375354A1 (en) Use of treosulfan and derivatives thereof for treating multiple sclerosis
ATE308321T1 (de) Verwendung von c2-substituierten indan-1-ol- systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas
ES2093515T3 (es) Aplicacion del riluzol como radio-restaurador.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 705099

Country of ref document: ES